Article Versions Notes

Lei F, Deng W, Zhou Y, Fang L, Lin X, Qin L, Li C, Rao J, Yu G. A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma. Cancers. 2026; 18(1):88. https://doi.org/10.3390/cancers18010088

Lei, Fangyong, Wenjing Deng, Ying Zhou, Lilan Fang, Xiuxin Lin, Lingyu Qin, Chunming Li, Jian Rao, and Gengsheng Yu. 2026. "A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma" Cancers 18, no. 1: 88. https://doi.org/10.3390/cancers18010088

Lei, F., Deng, W., Zhou, Y., Fang, L., Lin, X., Qin, L., Li, C., Rao, J., & Yu, G. (2026). A Phase II Study of Toripalimab in Combination with Gemcitabine and 5-Fluorouracil as First-Line Therapy for Advanced or Metastatic Biliary Tract Carcinoma. Cancers, 18(1), 88. https://doi.org/10.3390/cancers18010088